Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies

Exposure to proton pump inhibitors and risk of pancreatic cancer: a meta-analysis

(2020) Nasser Alkhushaym et al.   Expert Opinion On Drug Safety

Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population

(2020) Jeffrey K. Lee et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019

(2020) C. Bosetti et al.   ANNALS OF ONCOLOGY

Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysis

(2020) Hyun Jin Song et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Global Burden of 5 Major Types Of Gastrointestinal Cancer

(2020) Melina Arnold et al.   GASTROENTEROLOGY

Colorectal cancer occurrence and treatment based on changes in intestinal flora

(2020) Huifang Si et al.   SEMINARS IN CANCER BIOLOGY

Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study

(2020) Wei-Yi Lei et al.   Clinics and Research in Hepatology and Gastroenterology

Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies

(2020) Ana Babic et al.   BRITISH JOURNAL OF CANCER

Is antibiotics use really associated with increased risk of colorectal cancer? An updated systematic review and meta-analysis of observational studies

(2020) Guangbo Qu et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Effect of Proton Pump Inhibitors on Colorectal Cancer

(2020) Takamitsu Sasaki et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy

(2019) David Lundgren et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

The Clinician’s Guide to Proton Pump Inhibitor Related Adverse Events

(2019) Evan Elias et al.   DRUGS

Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults

(2019) Elena M. Stoffel et al.   GASTROENTEROLOGY

Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies

(2019) NaNa Keum et al.   Nature Reviews Gastroenterology & Hepatology

Gut microbiota in colorectal cancer: mechanisms of action and clinical applications

(2019) Sunny H. Wong et al.   Nature Reviews Gastroenterology & Hepatology

Reported proton pump inhibitor side effects: what are physician and patient perspectives and behaviour patterns?

(2019) Gaurav Ghosh et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy

(2019) Ana Montalban-Arques et al.   EBioMedicine

Significant association between the use of different proton pump inhibitors and microscopic colitis: a nationwide Danish case-control study

(2018) Ole K. Bonderup et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study

(2018) Neil Murphy et al.   Clinical Gastroenterology and Hepatology

Proton pump inhibitors: use and misuse in the clinical setting

(2018) Vincenzo Savarino et al.   Expert Review of Clinical Pharmacology

The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal

(2017) Vincenzo Savarino et al.   European Journal of Internal Medicine

Proton pump inhibitor ilaprazole suppresses cancer growth by targeting T-cell-originated protein kinase

(2017) Mengzhu Zheng et al.   Oncotarget

Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study

(2017) In Cheol Hwang et al.   PLoS One

Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study

(2016) James Turvill et al.   BRITISH JOURNAL OF GENERAL PRACTICE

Global patterns and trends in colorectal cancer incidence and mortality

(2016) Melina Arnold et al.   GUT

Inflammatory networks underlying colorectal cancer

(2016) Audrey Lasry et al.   NATURE IMMUNOLOGY

Pantoprazole, an FDA-approved proton-pump inhibitor, suppresses colorectal cancer growth by targeting T-cell-originated protein kinase

(2016) Xiaoyu Zeng et al.   Oncotarget

Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors

(2015) J. L. Schneider et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology

(2015) L. Lundell et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Low Prevalence of Colon Polyps in Chronic Inflammatory Conditions of the Colon

(2015) Amnon Sonnenberg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Proton pump inhibitors affect the gut microbiome

(2015) Floris Imhann et al.   GUT

Proton pump inhibitors alter the composition of the gut microbiota

(2015) Matthew A Jackson et al.   GUT

Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study

(2015) Monika Izano et al.   INTERNATIONAL JOURNAL OF CANCER

Trends in Prescription Drug Use Among Adults in the United States From 1999-2012

(2015) Elizabeth D. Kantor et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

How to read a funnel plot in a meta-analysis

(2015) Philip Sedgwick et al.   BMJ-British Medical Journal

How to read a funnel plot in a meta-analysis

(2015) Philip Sedgwick et al.   BMJ-British Medical Journal

Paradoxically Augmented Anti-Tumorigenic Action of Proton Pump Inhibitor and Gastrin in APCMin/+ Intestinal Polyposis Model1

(2015) Young-Min Han et al.   NEOPLASIA

Microscopic Colitis and Colorectal Neoplastic Lesion Rate in Chronic Nonbloody Diarrhea

(2014) Gian Eugenio Tontini et al.   INFLAMMATORY BOWEL DISEASES

Relative risks versus odds ratios

(2014) P. Sedgwick   BMJ-British Medical Journal

Use of proton pump inhibitors correlates with increased risk of colorectal cancer in Taiwan

(2013) Shih-Wei Lai et al.   Asia-Pacific Journal of Clinical Oncology

Gastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK

(2012) Ling-Jun Song et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats

(2011) Chinthalapally Rao   INTERNATIONAL JOURNAL OF ONCOLOGY

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Proton Pump Inhibitors and the Risk of Colorectal Cancer

(2010) Shicai Chen et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Colorectal cancer risk in relation to use of acid suppressive medications

(2009) Jessica Chubak et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Proton Pump Inhibitors and the Risk of Colorectal Cancer

(2008) Eva M. van Soest et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY